GHRP-6: uses, dosing & the facts
The original growth hormone releasing peptide. Similar to GHRP-2 but with even stronger appetite stimulation. First GHRP discovered. This is an evidence-graded reference — what it is, what it's used for, typical reported dosing, half-life, side effects, and how to track it. It is educational, not medical advice or a recommendation to use a research compound.
- • GHRP-6 — GHRP · GH secretagogue. The original growth hormone releasing peptide.
- • Commonly used for powerful appetite stimulation (bulking phases), growth hormone release, muscle growth.
- • Half-life: Approximately 20-30 minutes.
- • Status: Research use only · not FDA-approved — an educational reference, not a dose protocol or sourcing advice.
What GHRP-6 is
The original growth hormone releasing peptide. Similar to GHRP-2 but with even stronger appetite stimulation. First GHRP discovered.
What GHRP-6 is used for
- • Powerful appetite stimulation (bulking phases)
- • Growth hormone release
- • Muscle growth
- • Recovery enhancement
- • Aiding in weight gain
- • Increased food intake
These are reported/community uses, not proven clinical outcomes. Most research peptides have limited human trial data behind such claims.
Typical reported dosing
| Injectable | 100-200mcg injected subcutaneously 1-3x daily on empty stomach |
Presented as commonly-reported patterns for information only — not a dose recommendation. GHRP-6 dosing is a decision for a qualified clinician.
Reconstitution
Reconstitute with bacteriostatic water. The arithmetic is the same for any peptide: concentration = vial mg ÷ water mL, and on a U-100 syringe 100 units = 1 mL. Compute your own vial with the reconstitution calculator.
Half-life & cycling
Half-life: Approximately 20-30 minutes. Half-life drives dosing frequency and how quickly the compound clears — see it plotted on the half-life visualizer.
Cycling
Typical cycles: 8-12 weeks on, 4 weeks off. Best used during bulking phases due to appetite stimulation.
Side effects & warnings
- • Very strong appetite increase
- • Possible gastrointestinal discomfort
- • Water retention
- • Less selective than Ipamorelin
Very strong appetite stimulation makes it unsuitable for fat loss phases. Excellent for bulking and gaining weight. Use during periods where increased food intake is desired.
Tracking GHRP-6 in OptiPin
If you're tracking a GHRP-6 protocol, OptiPin logs each dose with reminders and site rotation, charts the outcome you care about over your dose timeline, keeps per-vial inventory with runout warnings, and (where relevant) does the reconstitution math — all on-device, no account.
Log doses, outcomes & vials in OptiPin
Reminders, outcome-over-dose charts, vial runout warnings, and built-in reconstitution math — all on-device.
Download on the App StoreFAQ
What is GHRP-6?
The original growth hormone releasing peptide. Similar to GHRP-2 but with even stronger appetite stimulation. First GHRP discovered.
What is GHRP-6 used for?
Commonly discussed uses include: powerful appetite stimulation (bulking phases), growth hormone release, muscle growth, recovery enhancement, aiding in weight gain, increased food intake. These are reported uses, not proven outcomes or a recommendation.
How is GHRP-6 dosed?
Commonly reported dosing: Injectable — 100-200mcg injected subcutaneously 1-3x daily on empty stomach. This reflects patterns discussed in the community and is presented for information only, not as a dose recommendation — GHRP-6 is not an approved medicine and dosing should involve a qualified clinician.
How do you reconstitute GHRP-6?
Reconstitute with bacteriostatic water. On a U-100 syringe, 100 units = 1 mL. Concentrations vary by vial, so compute from your own vial with a reconstitution calculator.
What is GHRP-6's half-life?
Approximately 20-30 minutes. Half-life shapes how often it is dosed and how quickly it clears.
What are GHRP-6's side effects?
Reported effects include: very strong appetite increase, possible gastrointestinal discomfort, water retention, less selective than ipamorelin. Because it is a research compound, its safety profile is not fully characterized; discuss risks with a clinician.
Evidence & further reading
- Search the peer-reviewed literature for GHRP-6 on PubMed (entry point to the primary evidence base, not a specific citation).
- GHRP-6 on ClinicalTrials.gov — registered human trials, if any.
- US FDA / 503A compounding status of research peptides (2026).
- OptiPin peptides guide — categories, evidence grading, and how to run a protocol honestly.
Related
GLP-2 · Hexarelin · IGF-1 LR3 · Ipamorelin · BPC-157 · TB-500 · Reconstitution calculator · All peptides